IQVIA is proud to announce that IQVIA Patient Suite has been recognized with a 2026 PM360 Innovation Award in the Clinical Trials category.

The PM360 Innovation Awards celebrate solutions that are helping advance the life sciences industry through innovation and meaningful impact. This recognition highlights IQVIA's commitment to supporting sponsors, sites, and patients throughout the clinical trial journey.

Patient Suite brings together a portfolio of participant-facing and study-supporting technologies, including Complete Consent (eConsent), Electronic Clinical Outcome Assessment (eCOA), Interactive Response Technology (IRT), and Connected Devices. Together, these solutions help organizations support participant engagement, capture critical study data, and manage key trial processes across a range of study designs.

The recognition reflects the continued evolution of Patient Suite and IQVIA's focus on addressing the challenges facing modern clinical research. As studies become more complex and increasingly global, sponsors and sites are seeking technologies that help simplify trial participation, support data collection, and improve operational efficiency. Patient Suite was developed to help meet these needs while supporting a more participant-centered research experience.

Over the past several years, IQVIA has continued to expand the capabilities of Patient Suite, enhancing digital trial experiences and supporting a broad range of study types and therapeutic areas worldwide. The award underscores IQVIA's ongoing commitment to delivering innovative technologies that help advance clinical research and support the development of new therapies.

Read the full award feature in the September issue of PM360.